There are 2789 resources available
1466P - Napabucasin + nab-paclitaxel with gemcitabine in patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC): Results from the phase III CanStem111P study
Presenter: Tanios Bekaii-Saab
Session: ePoster Display
1467P - POLO: Long-term safety and tolerability of olaparib for patients with a germline BRCA mutation and metastatic pancreatic cancer
Presenter: Dirk Arnold
Session: ePoster Display
1468P - POLO: Subsequent therapy after maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer
Presenter: Talia Golan
Session: ePoster Display
1470P - Oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence
Presenter: Thatcher Heumann
Session: ePoster Display
1471P - Overall survival by BRCA and ATM mutation status in patients with metastatic pancreatic cancer: Findings from the PRIOR-2 study
Presenter: Gboyega Adeboyeje
Session: ePoster Display
1586P - Assessment of side effects of radiation therapy in patients with COVID-19 treated for early-stage breast cancer
Presenter: sofiane allali
Session: ePoster Display
1587P - SARS-CoV-2 infection risk and COVID-19 prevalence in cancer patients during the first wave of COVID-19 pandemic in a Northern Italy’s virus epicenter area
Presenter: Antonino Musolino
Session: ePoster Display
1588P - SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19
Presenter: Meera Patel
Session: ePoster Display
1487TiP - A randomized non-comparative phase II study of maintenance therapy with FOLFIRI alone or in combination with Tedopi vaccine after induction therapy with FOLFIRINOX in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (TEDOPAM – D17-01 PRODIGE 63 STUDY)
Presenter: Marc Hilmi
Session: ePoster Display
1489P_PR - Tunisian children and adolescents coping with parental cancer
Presenter: Sinen Korbi
Session: ePoster Display